DHFB
Dixon Hubard Feinour & Brown Portfolio holdings
AUM
$842M
This Quarter Return
+4.2%
1 Year Return
-2.74%
3 Year Return
+59.83%
5 Year Return
+118.92%
10 Year Return
–
AUM
$315M
AUM Growth
+$315M
(-2.3%)
Cap. Flow
-$10.4M
Cap. Flow
% of AUM
-3.31%
Top 10 Holdings %
Top 10 Hldgs %
23.84%
Holding
189
New
18
Increased
34
Reduced
75
Closed
17
Top Buys
| 1 |
SPDR S&P Regional Banking ETF
KRE
|
$8.68M |
| 2 |
Charles Schwab
SCHW
|
$6.38M |
| 3 |
PetMed Express
PETS
|
$6.29M |
| 4 |
Helmerich & Payne
HP
|
$6.27M |
| 5 |
Amphenol
APH
|
$6.12M |
Top Sells
| 1 |
Home Depot
HD
|
$8.55M |
| 2 |
Edwards Lifesciences
EW
|
$7.71M |
| 3 |
Constellation Brands
STZ
|
$7.4M |
| 4 |
Thermo Fisher Scientific
TMO
|
$7M |
| 5 |
Lockheed Martin
LMT
|
$6.74M |
Sector Composition
| 1 | Healthcare | 19.83% |
| 2 | Technology | 16.72% |
| 3 | Industrials | 10.36% |
| 4 | Communication Services | 9.56% |
| 5 | Energy | 7.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
AbbVie
ABBV
$372B
| $4.69M | 1.49% |
74,918
-1,513
| -2% | -$94.7K |
|
27
Alphabet (Google) Class A
GOOGL
$2.57T
| $4.48M | 1.42% |
5,655
-58
| -1% | -$46K |
|
28
Pfizer
PFE
$141B
| $4.31M | 1.37% |
132,727
-1,480
| -1% | -$48.1K |
|
29
Bristol-Myers Squibb
BMY
$96B
| $3.78M | 1.2% |
64,746
-8,475
| -12% | -$495K |
|
30
Consolidated Edison
ED
$35.4B
| $3.48M | 1.1% |
47,163
+10
| +0% | +$737 |
|
31
Norfolk Southern
NSC
$62.8B
| $3.22M | 1.02% |
29,820
-1,277
| -4% | -$138K |
|
32
Southern Company
SO
$102B
| $3.03M | 0.96% |
61,663
+5,125
| +9% | +$252K |
|
33
Truist Financial
TFC
$60.4B
| $3.01M | 0.96% |
64,019
-750
| -1% | -$35.3K |
|
34
AT&T
T
$209B
| $2.98M | 0.95% |
69,996
-2,361
| -3% | -$100K |
|
35
PepsiCo
PEP
$204B
| $2.98M | 0.94% |
28,436
-7,137
| -20% | -$747K |
|
|
AGN
36
DELISTED
Allergan plc
AGN
| $2.9M | 0.92% |
13,824
-525
| -4% | -$110K |
|
37
Dominion Energy
D
$51.1B
| $2.88M | 0.92% |
37,646
-2,242
| -6% | -$172K |
|
38
Verizon
VZ
$186B
| $2.72M | 0.86% |
50,989
-2,764
| -5% | -$148K |
|
39
Vanguard FTSE Emerging Markets ETF
VWO
$96.4B
| $2.47M | 0.78% |
69,051
+5,670
| +9% | +$203K |
|
40
Intel
INTC
$107B
| $2.44M | 0.78% |
67,327
-425
| -0.6% | -$15.4K |
|
41
Nuveen Preferred & Income Opportunities Fund
JPC
$2.6B
| $2.43M | 0.77% |
247,150
+13,000
| +6% | +$128K |
|
42
Vanguard Real Estate ETF
VNQ
$34.6B
| $2.38M | 0.75% |
28,803
+950
| +3% | +$78.4K |
|
43
Travelers Companies
TRV
$61.1B
| $2.25M | 0.71% |
18,391
-650
| -3% | -$79.6K |
|
44
International Paper
IP
$26.2B
| $2.2M | 0.7% |
41,416
+2,370
| +6% | +$126K |
|
45
Eli Lilly
LLY
$657B
| $2.15M | 0.68% |
29,290
-1,145
| -4% | -$84.2K |
|
46
Chevron
CVX
$324B
| $2M | 0.63% |
16,995
+510
| +3% | +$60K |
|
47
Nuveen Municipal Value Fund
NUV
$1.8B
| $1.96M | 0.62% |
205,185
+19,310
| +10% | +$185K |
|
48
Atlantic Union Bankshares
AUB
$5.09B
| $1.93M | 0.61% |
54,111
| – | – |
|
49
Cisco
CSCO
$274B
| $1.93M | 0.61% |
63,972
+2,167
| +4% | +$65.5K |
|
50
Healthpeak Properties
DOC
$12.5B
| $1.85M | 0.59% |
62,356
-3,270
| -5% | -$97.2K |
|